BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 34654367)

  • 1. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
    Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
    BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study.
    Wu X; Xu L; Cheng Q; Nie L; Zhang S; Du Y; Xue J
    Respir Med; 2020 May; 166():105948. PubMed ID: 32250876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers.
    Lucchino B; Di Paolo M; Gioia C; Vomero M; Diacinti D; Mollica C; Alessandri C; Diacinti D; Palange P; Di Franco M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
    Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
    Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study.
    Matsuo T; Hashimoto M; Ito I; Kubo T; Uozumi R; Furu M; Ito H; Fujii T; Tanaka M; Terao C; Kono H; Mori M; Hamaguchi M; Yamamoto W; Ohmura K; Morita S; Mimori T
    Scand J Rheumatol; 2019 Mar; 48(2):87-94. PubMed ID: 30269670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: Rheumatoid arthritis-associated interstitial lung disease.
    Hussein MS; El-Barbary AM; Nada DW; Gaber RA; Elkolaly RM; Aboelhawa MA
    Int J Rheum Dis; 2021 Apr; 24(4):591-598. PubMed ID: 33638296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
    Wan J; Yu Z; Cao X; Zhao X; Zhou W; Zheng Y
    Clin Rheumatol; 2024 Jun; 43(6):1855-1863. PubMed ID: 38704780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Qiu M; Jiang J; Nian X; Wang Y; Yu P; Song J; Zou S
    Respir Res; 2021 Oct; 22(1):264. PubMed ID: 34635095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
    Chen N; Diao CY; Gao J; Zhao DB
    Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Wnt7b protein in rheumatoid arthritis: Detection of interstitial lung disease.
    Rabie M; El-Hady HIA; Ibrahim DA; Hassan TH; Abdelhady EI
    Immunobiology; 2023 Jul; 228(4):152397. PubMed ID: 37290224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease.
    Fang Q; Xie J; Zong J; Zhou Y; Zhou Q; Yin S; Cao L; Yin H; Zhou D
    Int Immunopharmacol; 2024 Jun; 134():112173. PubMed ID: 38728884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease.
    Castellanos-Moreira R; Rodríguez-García SC; Gomara MJ; Ruiz-Esquide V; Cuervo A; Casafont-Solé I; Ramírez J; Holgado S; Gómez-Puerta JA; Cañete JD; Haro I; Sanmarti R
    Ann Rheum Dis; 2020 May; 79(5):587-594. PubMed ID: 32156708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Uric Acid as a Diagnostic Biomarker for Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Wang Z; Wang W; Xiang T; Gong B; Xie J
    Inflammation; 2022 Aug; 45(4):1800-1814. PubMed ID: 35314903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
    Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
    Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis-associated interstitial lung disease.
    Fotoh DS; Helal A; Rizk MS; Esaily HA
    Clin Rheumatol; 2021 Jul; 40(7):2689-2697. PubMed ID: 33474659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of rheumatoid arthritis-associated interstitial lung disease.
    Wang T; Zheng XJ; Liang BM; Liang ZA
    Sci Rep; 2015 Oct; 5():14897. PubMed ID: 26443305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.